Sponsors (2)
The bill invests targeted federal funds and data-driven evaluation to expand preventive cardiovascular services for high-risk women and improve program accountability, but it increases federal spending and administrative demands and risks leaving some eligible women out if eligibility is narrowly defined.
High-risk women will receive expanded preventive screenings (blood pressure, cholesterol, obesity), evidence-based health education, and referrals with follow-up, improving early detection and management of cardiovascular and related conditions.
The bill provides dedicated federal funding ($250 million over 2027–2031) to expand preventive service capacity and requires evaluation and reporting, strengthening program capacity and accountability at CDC and local programs.
Public-health planners, GAO, and Congress will get better data and a cost-effectiveness lens to identify inefficient practices and guide future funding or program design improvements, potentially improving value for taxpayers.
Taxpayers face increased federal spending (up to $250 million) and potential future cost increases if programs expand without offsetting funds.
Providers and governments will incur additional administrative, reporting, and evaluation burdens and may need new staff or systems, and state/localities may face pressure to fill identified service gaps with limited resources.
If the Secretary-defined eligibility is narrow or variably applied, some high-risk women—particularly low-income or marginalized individuals—could be excluded from services despite the bill's intent to expand access.
Based on analysis of 6 sections of legislative text.
Authorizes CDC supplemental WISEWOMAN grants to expand cardiovascular screenings, education, referrals, and evaluation and authorizes $250M for FY2027–2031.
Introduced February 26, 2026 by Angela Deneece Alsobrooks · Last progress February 26, 2026
Expands the CDC’s WISEWOMAN preventive services by authorizing supplemental grants to provide cardiovascular risk screenings (blood pressure, cholesterol, obesity, and other risk factors), evidence-based health education, referrals and follow-up, and program evaluation with reporting to the Secretary. The measure authorizes $250 million for fiscal years 2027–2031 to carry out these grants and requires the GAO to report by September 30, 2027 on program reach, barriers, trends, and cost-effectiveness.